Global Postpartum Depression Market Size and Forecast 2023-2032|Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co., AbbVie Inc., Novartis AG,

The Business Research Company’s Postpartum Depression Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Postpartum Depression Global Market Report 2023 evaluates postpartum depression market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=13024&type=smp

The global postpartum depression market is expected to grow from $9.17 billion in 2023 to $12.15 billion in 2024 at a compound annual growth rate (CAGR) of 32.5%. The growth in the historic period can be attributed to maternal mental health awareness, research advancements, public health initiatives, increased screenings.The postpartum depression market size is expected to see exponential growth in the next few years. It will grow to $36.96 billion in 2028 at a compound annual growth rate (CAGR) of 32.1%.

An increase in postpartum depression cases is expected to propel the growth of the postpartum depression market going forward. Postpartum depression is an exaggerated worry that develops after giving birth. There may be physical symptoms in addition to it. Postnatal depression and postpartum anxiety frequently coexist and in the first year after giving birth, symptoms might start at any time. Postpartum depression is frequently treated with psychotherapy, commonly known as talk therapy or mental health counseling, medication, or a combination of the two, which results in the growth of the market. For Instance, in May 2022, according to UVA Medical Center, a US-based academic medical center with hospitals and specialty clinics, in the US the rates of postpartum depression symptoms steadily increased by 7.7% between December 2020 and March 2021. Further, there was an increase in postpartum depression symptoms in 36 of the 50 U.S. states and the District of Columbia in 2021. Therefore, an increase in postpartum depression cases will drive the postpartum depression market.

Get More Information On The Postpartum Depression Market Report:

https://www.thebusinessresearchcompany.com/report/postpartum-depression-global-market-report

The postpartum depression market segments in the report are:

1) By Types: Postpartum Blues, Postpartum Anxiety, Postpartum Obsessive Compulsive Disorder, Postpartum Panic Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Psychosis, Other Types

2) By Treatment: Psychotherapy, Medication, Supplements, Other Treatments

3) By Route of Administration: Oral, Parenteral, Other Route Of Administration

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

The table of contents in TBRC’s postpartum depression market report includes:

1. Executive Summary

2. Postpartum Depression Market Characteristics

3. Postpartum Depression Market Trends And Strategies

4. Postpartum Depression Market – Macro Economic Scenario

5. Global Postpartum Depression Market Size and Growth

.

.

.

26. South America Postpartum Depression Market

27. Brazil Postpartum Depression Market

28. Middle East Postpartum Depression Market

29. Africa Postpartum Depression Market

30. Postpartum Depression Market Competitive Landscape And Company Profiles

Top Major Players:

• Pfizer Inc
• Johnson & Johnson
• Roche Holding AG
• Merck & Co
• AbbVie Inc

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model